Nature Medicine, Published online: 10 March 2025; doi:10.1038/s41591-025-03572-3In a randomized phase 3 trial, the combination of the BET inhibitor pelabresib
Nature Medicine, Published online: 10 March 2025; doi:10.1038/s41591-025-03572-3In a randomized phase 3 trial, the combination of the BET inhibitor pelabresib
Nature Medicine, Published online: 10 March 2025; doi:10.1038/s41591-025-03568-zAnalyses of pretransplant omics data from different cohorts of African American recipients found
Nature Medicine, Published online: 10 March 2025; doi:10.1038/s41591-025-03568-zAnalyses of pretransplant omics data from different cohorts of African American recipients found
ROCKVILLE, Md., March 10, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced new interim biomarker data from the Phase
ROCKVILLE, Md., March 10, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced new interim biomarker data from the Phase
Sehgal will focus on expanding biofuel projects to meet India's growing need for sustainable energy.
Sehgal will focus on expanding biofuel projects to meet India's growing need for sustainable energy.